Ouchen Wang

Pr
Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

HiCAF-Net: A Hierarchical Cross-Attention Fusion framework for cross-cancer subtype classification using histopathological and genomic data.

HiCAF-Net: A Hierarchical Cross-Attention Fusion framework for cross-cancer subtype classification using histopathological and genomic data.

Journal: Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society

Published: January 06, 2026

Cathepsins E, O, and S: Novel Biomarkers and Therapeutic Targets in Breast Carcinoma.

Cathepsins E, O, and S: Novel Biomarkers and Therapeutic Targets in Breast Carcinoma.

Journal: Current medicinal chemistry

Published: April 21, 2025

Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial.

Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial.

Journal: eLife

Published: April 03, 2025

Corrigendum to: Downregulating integrin subunit alpha 7 (ITGA7) promotes proliferation, invasion, and migration of papillary thyroid carcinoma cells through regulating epithelial-to-mesenchymal transition.

Corrigendum to: Downregulating integrin subunit alpha 7 (ITGA7) promotes proliferation, invasion, and migration of papillary thyroid carcinoma cells through regulating epithelial-to-mesenchymal transition.

Journal: Acta biochimica et biophysica Sinica

Published: December 03, 2024

α-Hederin causes ferroptosis in triple-negative breast cancer through modulating IRF1 to suppress GPX4.

α-Hederin causes ferroptosis in triple-negative breast cancer through modulating IRF1 to suppress GPX4.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 30, 2024

The PDE4DIP-AKAP9 axis promotes lung cancer growth through modulation of PKA signalling.

The PDE4DIP-AKAP9 axis promotes lung cancer growth through modulation of PKA signalling.

Journal: Communications biology

Published: February 27, 2024

Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China.

Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China.

Journal: Cancer

Published: December 28, 2023

Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Journal: Oncology research and treatment

Published: March 26, 2023

PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis.

PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis.

Journal: Cell death & disease

Published: January 17, 2023

LINC00891 Promotes Tumorigenesis and Metastasis of Thyroid Cancer by Regulating SMAD2/3 via EZH2.

LINC00891 Promotes Tumorigenesis and Metastasis of Thyroid Cancer by Regulating SMAD2/3 via EZH2.

Journal: Current medicinal chemistry

Published: December 18, 2022

Radiomics-based signature of breast cancer on preoperative contrast-enhanced MRI to predict axillary metastasis.

Radiomics-based signature of breast cancer on preoperative contrast-enhanced MRI to predict axillary metastasis.

Journal: Future oncology (London, England)

Published: December 08, 2022

A Multicenter, Randomized, Controlled Study of the Breast Biopsy and Circumferential Excision System for Breast Lesions.

A Multicenter, Randomized, Controlled Study of the Breast Biopsy and Circumferential Excision System for Breast Lesions.

Journal: Clinical breast cancer

Published: November 04, 2022

Showing 1-12 of 61

Last Updated: 09/26/2026